Long-term aspirin use and neovascular age-related macular degeneration: Association or causation?

Evidence-Based Medicine

Volumn 19, Issue 1, 2014, Pages

  Christen, William G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CHOLESTEROL;

BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG USE; EYE PHOTOGRAPHY; FOLLOW UP; FOOD INTAKE; HUMAN; LONG TERM CARE; MEDICAL HISTORY; NOTE; POPULATION RESEARCH; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SMOKING; STRUCTURED INTERVIEW; SYSTOLIC BLOOD PRESSURE;

ASPIRIN; FEMALE; HUMANS; MACULAR DEGENERATION; MALE;

EID: 84895511438     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2013-101358     Document Type: Note

References (4)

1. De Jong PT, Chakravarthy U, Rahu M, et al. Associations between aspirin use and aging macula disorder: the European eye study. Ophthalmology 2012;119: 112-18.
2. Klein BE, Howard KP, Gangnon RE, et al. Long-term use of aspirin and age-related macular degeneration. JAMA 308: 2469-78.
3. Christen WG, Glynn RJ, Ajani UA, et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 2001;119: 1143-9.
4. Christen WG, Glynn RJ, Chew EY, et al. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology 2009;116: 2386-92.